Results
|
|
1.
|
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors:
Year: 2017
Citation: - Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
All authors: - Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors:
Year: 2013
Citation: - Oncologist. 18(3):257-64, 2013.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM
|
|
|
12.
|
What is your diagnosis? Anal mucosal melanoma. MedStar authors:
Year: 2012
Citation: - Cutis. 89(3):112, 116, 140, 2012 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
- Case Reports
- Journal Article
All authors: - Minor DS, Shoo BA, Venna SS
|
|
|
13.
|
|
|
|
14.
|
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA. MedStar authors:
Year: 2014
Citation: - Annals of Oncology. 25(6):1116-21, 2014 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Cortes J, Im YH, Lee LF, Miles D, Quah C, Swain SM
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. MedStar authors:
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):235-51, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Amiri-Kordestani L, Chavez KJ, Conway CM, Dine JL, Greer YE, Hewitt SM, Lipkowitz S, Merchant AS, O'Sullivan CC, Sinclair S, Steinberg SM, Stone B, Swain SM, Voeller D
|
|
|
18.
|
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. MedStar authors:
Year: 2016
Citation: - Cancer Epidemiology, Biomarkers & Prevention. 25(1):51-9, 2016 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Anderson SJ, Cecchini RS, Costantino JP, Geyer CE Jr, Jeong JH, Lembersky BC, Paterson AH, Rastogi P, Romond EH, Swain SM, Tang G, Wolmark N
|
|
|
19.
|
|
|
|
20.
|
|
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. MedStar authors:
Year: 2018
Citation: - Annals of Surgical Oncology. 25(3):667-673, 2018 Mar.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baratti D, Chouliaras K, De Simone M, Deraco M, Elias D, Glehen O, Heyd B, Kusamura S, Levine EA, Morris D, RENAPE Working Group, Robella M, Russell G, Shen P, Sugarbaker P, Votanopoulos KI
|
|
|
24.
|
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. MedStar authors:
Year: 2016
Citation: - Annals of Surgical Oncology. 24(7):1853-1860, 2017 Jul
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Kidwell KM, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA, Zoon CK
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts. MedStar authors:
Year: 2020
Citation: - Clinical Colorectal Cancer. 19(4):277-284, 2020 12.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Beate R, Brandon M, Claudio Q, David M, Diane G, Ignace H, Janina E, Lana B, Markus G, Martin PP, Olivier G, Paul S, Pompiliu P, Steffen T, Yan L, Yutaka Y
|
|
|
32.
|
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. MedStar authors:
- Lynce, Filipa
- Swain, Sandra M
Year: 2020
Citation: - Frontiers in Oncology. 10:1475, 2020.
Institution: - Washington Cancer Institute
Department:
- Associate Dean for Research Development
- MedStar Health
Medline publication type:
All authors: - Elliott A, Gatalica Z, Heeke AL, Isaacs C, Khoury K, Korn WM, Lynce F, Pohlmann PR, Schwartzberg LS, Simon M, Swain SM, Tan AR, Xiu J
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
|
|
|
37.
|
|
|
|
38.
|
|
|
|
39.
|
|
|
|
40.
|
Adjuvant HIPEC for gastric cancer. MedStar authors:
Year: 2021
Citation: - Journal of Gastrointestinal Oncology. 12(Suppl 1):S18-S19, 2021 Apr.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Sugarbaker PH, Van der Speeten K
|
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
Quality of life and toxicity outcomes for patients with early stage breast cancer treated with intra-operative radiation therapy: a prospective analysis MedStar authors:
Year: 2015
Institution: - Washington Cancer Institute
All authors: - Costellic C, Gulla A, Hechenbleikner E, Clarke J, Collins B, Rudra S, Chaldekas K, Seevaratnam S, Langan R, Gary M, Willey S, Tousimis E
|
|
|
46.
|
Role of cardiac CT as a screening test for CAD detection in long-term Allogeneic Stem Cell Transplant (allo-SCT) survivors MedStar authors:
Year: 2015
Institution: - Washington Cancer Institute
All authors: - Jain NA, Chen MY, Shanbhag S, Anandi P, Lu K, Pophali P, Ito S, Koklanaris E, Hourigan CS, Barrett AJ, Battiwalla M
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
Quality of life and toxicity outcomes for patients with early stage breast cancer treated with intra-operative radiation therapy: a prospective analysis MedStar authors:
Year: 2015
Institution: - Washington Cancer Institute
All authors: - Costellic C, Gulla A, Hechenbleikner E, Clarke J, Collins B, Rudra S, Chaldekas K, Seevaratnam S, Langan R, Gary M, Willey S, Tousimis E
|
|
|
50.
|
|
|
|
51.
|
|
|
|
52.
|
|
|
|
53.
|
|
|
|
54.
|
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
|
|
|
58.
|
|
|
|
59.
|
|
|
|
60.
|
|
|
|
61.
|
|
|
|
62.
|
Early Outpatient Treatment for Covid-19 with Convalescent Plasma. MedStar authors:
Year: 2022
Citation: - New England Journal of Medicine. 386(18):1700-1711, 2022 05 05.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Abinante M, Anjan S, Appel LJ, Baksh SN, Blair JE, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cluzet VC, Cordisco ME, Cruser D, Currier JS, Ehrhardt S, Ford DE, Forthal DN, Foster EC, Fukuta Y, Gawad AL, Gebo KA, Gerber JM, Gniadek TJ, Greenblatt B, Hammel J, Hammitt LL, Hanley DF, Heath SL, Huaman MA, Jabs DA, Karlen N, Kassaye SG, Klein SL, Laeyendecker O, Lane K, Lau B, Levine AC, Marshall CE, McBee NA, Meisenberg BR, Mosnaim GS, Oei K, Patel B, Paxton JH, Pekosz A, Petrini JR, Rausch W, Raval JS, Roth M, Shade DM, Shenoy AG, Shoham S, Singh A, Spivak ES, Sullivan DJ, Sutcliffe CG, Tobian AAR, Yarava A, Zand MS
|
|
|
63.
|
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?. MedStar authors:
Year: 2022
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Abinante M, Adamski J, Anjan S, Bloch EM, Broderick PB, Cachay ER, Casadevall A, Cruser D, Forthal D, Fukuta Y, Gawad A, Gebo KA, Gerber J, Gniadek TJ, Hanley DF, Heath SL, Huaman MA, Kafka K, Kassaye SG, Lane K, Levine A, Marshall C, McBee N, Meisenberg BR, Metcalf RA, Mosnaim GS, Patel B, Paxton JH, Raval JS, Reisler RB, Shenoy A, Shoham S, Sullivan D, Tobian AAR, Yarava A, Zand M, Ziman A
|
|
|
64.
|
|
|
|
65.
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. MedStar authors:
Year: 2013
Citation: - Journal of the National Cancer Institute. 105(23):1782-8, 2013 Dec 4.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Bandos H, Blackmon NL, Bohn OL, Burandt E, Costantino JP, Fehrenbacher L, Fumagalli D, Gavin PG, Geyer CE Jr, Goldstein LC, Horne ZD, Jeong JH, Kim C, Kim SI, Kim SR, Lee A, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Reilly ML, Remillard MY, Romond EH, Sneige N, Swain SM, Tanaka N, Taniyama Y, Wickerham DL, Wolmark N
|
|
|
66.
|
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. MedStar authors:
Year: 2013
Citation: - Clinical Cancer Research. 19(13):3681-92, 2013 Jul 1.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bais C, Brauer MJ, Chen D, Cheng JH, Chung AS, Clermont AC, Ferrara N, Haley B, Hegde P, James CD, Jubb A, Jurinka SS, Kaminker JS, Koeppen H, Kolumam G, Modrusan Z, Ozawa T, Phillips H, Scherer SJ, Schmidt M, Singh M, Stephan JP, Swain SM, Tam RN, Wu X, Yang SX, Yao J, Yeh RF, Yue P, Zhuang G
|
|
|
67.
|
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors:
Year: 2013
Citation: - Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J
|
|
|
68.
|
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM
|
|
|
69.
|
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors:
Year: 2014
Citation: - BMC Cancer. 14:307, 2014.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B
|
|
|
70.
|
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors:
Year: 2015
Citation: - New England Journal of Medicine. 372(8):724-34, 2015 Feb 19.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM
|
|
|
71.
|
|
|
|
72.
|
Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Oncology. 33(12):1340-7, 2015 Apr 20.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blackmon NL, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Kim SR, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
73.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
|
74.
|
Deleterious BRCA1/2 mutations in an urban population of Black women. MedStar authors:
- Fries, Melissa
- Lynce, Filipa
Year: 2015
Citation: - Breast Cancer Research & Treatment. 153(1):201-9, 2015 Aug.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - DeMarco T, Fries M, Isaacs C, Lynce F, Peshkin BN, Smith KL, Stein J, Wang H, Wang Y
|
|
|
75.
|
|
|
|
76.
|
|
|
|
77.
|
|
|
|
78.
|
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
Year: 2017
Citation: - JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
79.
|
|
|
|
80.
|
The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. MedStar authors:
Year: 2016
Citation: - Indian Journal of Surgical Oncology. 7(2):160-5, 2016 Jun
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bhatt A, Mahajan V, Mehta S, Raj EH, Rajan F, Seshadri RA, Sethna K, Singh S, Sugarbaker PH, Zaveri S
|
|
|
81.
|
|
|
|
82.
|
|
|
|
83.
|
|
|
|
84.
|
|
|
|
85.
|
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. MedStar authors:
Year: 2017
Citation:
- JAMA Oncology. , 2017 Feb 09
- JAMA Oncology. 3(7):944-952, 2017 Jul 01
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baker LH, Benjamin RS, Blackstein ME, Blanke CD, Borden EC, Corless CL, Crowley JJ, Demetri GD, Fletcher JA, Heinrich M, Maki RG, Owzar K, Priebat DA, Rankin C, Ryan CW, Tap WD, von Mehren M
|
|
|
86.
|
|
|
|
87.
|
|
|
|
88.
|
|
|
|
89.
|
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors:
- Swain, Sandra M
- Zapas, John L
Year: 2017
Citation: - Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL
|
|
|
90.
|
|
|
|
91.
|
|
|
|
92.
|
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. MedStar authors:
Year: 2018
Citation:
- Annals of Surgical Oncology. 2018 Feb 26
- Annals of Surgical Oncology. 25(5):1184-1192, 2018 May.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Baumgartner JM, BIG-RENAPE Group, Cashin P, Ceelen W, de Hingh I, Deraco M, Elias D, Fushita S, Glehen O, Goere D, Katayama K, Kusamura S, Levine EA, Liu Y, Morris DL, Piso P, Pocard M, Quenet F, Spiliotis JD, Sugarbaker PH, Tuech JJ, Yonemura Y
|
|
|
93.
|
|
|
|
94.
|
|
|
|
95.
|
|
|
|
96.
|
Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer. MedStar authors:
Year: 2020
Citation: - Journal of Community Genetics. 11(1):85-99, 2020 Jan.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Anderson L, Campos C, Carrera P, Cupertino AP, Ficca N, Gomez-Trillos S, Gonzalez N, Graves KD, Huerta E, Hurtado-de-Mendoza A, Ostrove N, Otero A, Peshkin BN, Schwartz MD, Sheppard VB, Song M
|
|
|
97.
|
|
|
|
98.
|
|
|
|
99.
|
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
Year: 2020
Citation: - Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
|
|
|
100.
|
Hyperthermic intraoperative thoracoabdominal chemotherapy. MedStar authors:
- Stuart, O Anthony
- Sugarbaker, Paul H
Year: 2012
Citation: - Gastroenterology research & practice. 2012:623417, 2012.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Chang D, Stuart OA, Sugarbaker PH
|
